课题基金 / 基金详情

The Neural Mechanisms of Hypertension

The Neural Mechanisms of Hypertension
高血压的神经机制
批准号:
9061371
负责人:
Yumei Feng Earley
金额:
$25.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-12-15 至 2019-11-30

项目摘要

项目成果

Yumei Feng Earley的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):尽管最近在药物治疗和急性病人护理方面取得了进展,心血管疾病(CVD)仍然是发病率和死亡率的主要原因。高血压是心血管疾病的主要危险因素,导致95%的心血管疾病死亡。盐敏感性高血压(SSH)是人类原发性高血压的主要形式。末梢板和下丘脑室旁核的中枢机制在SSH的发生发展中起重要作用;特别是,PVN中的血管紧张素II (Ang II) 1型受体(AT1R)介导交感神经张力和血压(BP)的升高,以应对高盐。肾素受体(PRR)是新近发现的肾素-血管紧张素系统(RAS)的组成部分。肾素或prorentin与PRR结合可促进Ang II的形成并激活Ang II独立的丝裂原活化蛋白激酶(MAPK)信号。我们的初步数据显示,PRR表达水平在高血压人类受试者的PVN中升高,但这种升高在高血压期间的意义尚不清楚。我们的中心假设是,PVN中PRR表达的升高通过增加局部Ang II的形成和增强细胞内MAPK信号的激活来促进SSH的发病机制。为了验证我们的假设,我们在神经元特异性神经丝- h (Nefh)启动子的控制下,将表达Cre重组酶的PRR-floxed小鼠与表达Cre重组酶的小鼠杂交,获得了PRR-floxed小鼠产生的PRR条件敲除小鼠模型(Nefh- prrko)。在本提案中,我们将在这些新型小鼠模型中诱导SSH,结合PVN微注射技术和最先进的遥测记录来验证我们的假设。我们的目的是描述SSH中PRR信号通路在PVN中的功能重要性,以及导致SSH中PRR升高的表观遗传机制。以下具体目标将被解决:1)确定PVN中的PRR激活是否介导SSH的发展。2)阐明PVN中prr介导的MAPK信号在SSH中的作用。3)明确SSH患者PVN中PRR表达升高的机制。本研究将揭示PVN PRR在SSH中的作用,并阐明潜在的信号机制。这些研究的成功完成,填补了PRR在SSH中的重要性的知识空白,提供了新的治疗靶点,将对SSH的治疗产生重大的积极影响。
英文摘要
DESCRIPTION (provided by applicant): Cardiovascular diseases (CVD) remain a leading cause of morbidity and mortality despite recent advances in pharmacological therapy and acute patient care. Hypertension is the major risk factor for CVD and contributes to 95% of CVD deaths. Salt-sensitive hypertension (SSH) is a major form of human primary hypertension. The central mechanisms involving the lamina terminalis and the paraventricular nucleus of the hypothalamus (PVN) play an important role in the development of SSH; in particular, the angiotensin II (Ang II) type 1 receptor (AT1R) in the PVN mediates elevation in sympathetic tone and blood pressure (BP) in response to high salt. The (pro)renin receptor (PRR) is a newly discovered component of the renin-angiotensin system (RAS). Binding of renin or prorenin to PRR promotes Ang II formation and activates Ang II-independent mitogen-activated protein kinases (MAPK) signals. Our preliminary data show that PRR expression levels are elevated in the PVN of hypertensive human subjects, but the significance of this elevation during hypertension is not known. Our central hypothesis is that elevated PRR expression in the PVN contributes to the pathogenesis of SSH by increasing local Ang II formation and enhancing the intracellular MAPK signal activation. To test our hypothesis, we have obtained PRR-floxed mice generated a PRR conditional knockout mouse model (Nefh-PRRKO) by breeding PRR-floxed mice with mice expressing Cre recombinase under the control of neuron-specific neurofilament-H (Nefh) promoter. In this proposal, we will induce SSH in these novel mouse models, combined with PVN micro-injection technique and state-of-the-art telemetry recording to test our hypothesis. Our objective is to delineate the functional importance of PRR signaling pathways in the PVN in SSH, and the epigenetic mechanisms leading to PRR elevation in SSH. The following specific aims will be addressed: 1) Determine if PRR activation in the PVN mediates the development of SSH. 2) Elucidate the contribution of PRR-mediated MAPK signaling in the PVN to SSH. 3) Identify the mechanisms responsible for elevated PRR expression in the PVN in SSH. The proposed research will uncover the role of PVN PRR in SSH and elucidate the underlying signaling mechanisms. The successful completion of these studies will have a significant positive impact on the treatment of SSH by filling the knowledge gap of the importance PRR in SSH and providing a novel therapeutic target.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neural mechanisms regulating glucose homeostasis
  • 批准号:
    10634249
  • 项目类别:
  • 资助金额:
    $56.34万
  • 财政年份:
    2023
  • 负责人:
    Yumei Feng Earley
  • 依托单位:
Transgenic Animal Genotyping and Phenotyping Core
  • 批准号:
    10332747
  • 项目类别:
  • 资助金额:
    $33.51万
  • 财政年份:
    2019
  • 负责人:
    Yumei Feng Earley
  • 依托单位:
Transgenic Animal Genotyping and Phenotyping Core
  • 批准号:
    10558650
  • 项目类别:
  • 资助金额:
    $30.95万
  • 财政年份:
    2019
  • 负责人:
    Yumei Feng Earley
  • 依托单位:
Transgenic Animal Genotyping and Phenotyping Core
  • 批准号:
    10077905
  • 项目类别:
  • 资助金额:
    $27.04万
  • 财政年份:
    2019
  • 负责人:
    Yumei Feng Earley
  • 依托单位:
海外基金